Moderna Cancer Treatment Shows Promise in Clinical Trial

Why it matters locally: Moderna, a company with significant operations and a substantial workforce in Massachusetts, is developing this experimental treatment. Positive clinical trial results for their therapies could have a direct impact on the state's biotechnology sector and employment.

---

Moderna's shares increased after the company announced positive results for its experimental mRNA-based cancer treatment. The therapy, called intismeran, is under development in collaboration with Merck. Researchers designed intismeran to be customized for individual patients. It targets specific mutations found within each patient's tumor.